Key result
Equipping CAD patients with a 12-lead ECG device and 24-hour telemedicine availability did not decrease the risk for the composite endpoint compared to control (40% vs 38%).
Why the study?
Does equipping CAD patients with a 12-lead ECG device and providing a 24-hour telemedicine centre reduce the composite endpoint of all-cause mortality, myocardial infarction, re-hospitalization or re-vascularization?
Population
1500 patients with established coronary artery disease (CAD)
Comparison
Equipped with a 12-lead event recorder and could… vs Control group
Design
RCT, randomized to control or intervention groups
Follow-up
12 months
Authors
Loading...
Does not support routine telemedicine ECG use in CAD; confirms lack of benefit for composite events in secondary prevention.
RCT (n=1,500)
randomized
Does equipping CAD patients with a 12-lead ECG device and providing a 24-hour telemedicine centre reduce the composite endpoint of all-cause mortality, myocardial infarction, re-hospitalization or re-vascularization?
Absolute Event Rate: 40% vs 38%
Additional telemedicine care with a 12-lead ECG device and 24-hour call center did not reduce morbidity and mortality in patients with established CAD over 12 months.
Waldmann et al. (2008) conducted an RCT in established coronary artery disease (CAD) (n=1,500). 12-lead event recorder and 24-hour telemedicine centre availability vs. control was evaluated on composite endpoint (all-cause mortality, myocardial infarction, re-hospitalization or re-vascularization). Equipping CAD patients with a 12-lead ECG device and 24-hour telemedicine availability did not decrease the risk for the composite endpoint compared to control (40% vs 38%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: